ResMed | RMD - Debt


ResMed reported $846.35M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Ansell USD 805.6M 51.6M Jun/2025
AtriCure USD 76.73M 521K Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Cochlear AUD 235.7M 10.9M Jun/2025
Cooper Companies USD 2.48B 285.1M Jun/2025
CSL USD 11.96B 219M Dec/2024
Dexcom USD 1.24B 1.21B Dec/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
Globus Medical USD 119.34M 1.76M Sep/2025
Haemonetics USD 1.22B 54K Sep/2025
Hologic USD 2.63B 104.3M Sep/2025
Idexx Laboratories USD 1.11B 124.31M Sep/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 642.2M 299.4M Jun/2025
Medtronic USD 29.1B 491M Sep/2025
Philips EUR 8.38B 41M Sep/2025
Ramsay Health Care AUD 12.12B 864.4M Jun/2025
ResMed USD 846.35M 178.06M Sep/2025
Sigma Healthcare AUD 137.64M 1.01M Jul/2024
Sonic Healthcare AUD 4.8B 282.9M Dec/2024
Steris USD 2.06B 10.4M Sep/2025
Teleflex USD 2B 180.08M Jun/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025